相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Database resources of the national center for biotechnology information
Eric W. Sayers et al.
NUCLEIC ACIDS RESEARCH (2022)
CAR T cell therapy in solid tumors: a short review
Oyku Umut et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2021)
CAR T-Cell Therapy in Hematologic Malignancies: A Voyage in Progress
Sarah A. Holstein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8
Hiroki Tadano et al.
BRITISH JOURNAL OF CANCER (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner et al.
MOLECULAR THERAPY (2020)
Target selection for CAR-T therapy
Jianshu Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Cellular stress induces cancer stem-like cells through expression of DNAJB8 by activation of heat shock factor 1
Hiroki Kusumoto et al.
CANCER SCIENCE (2018)
The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer
Sho Miyamoto et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response
Masamichi Yamashita et al.
PLOS ONE (2016)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
CAR T Cells for Solid Tumors Armed and Ready to Go?
Sunitha Kakarla et al.
CANCER JOURNAL (2014)
Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells
Rena Morita et al.
CANCER SCIENCE (2014)
The DNAJB6 and DNAJB8 Protein Chaperones Prevent Intracellular Aggregation of Polyglutamine Peptides
Judith Gillis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem-like Cells
Satoshi Nishizawa et al.
CANCER RESEARCH (2012)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein Aggregation
Jurre Hageman et al.
MOLECULAR CELL (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas
M. Murase et al.
BRITISH JOURNAL OF CANCER (2009)
TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning
CA Aarnoudse et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay
K Kuzushima et al.
BLOOD (2001)
分享论文
